Cepheid Danaher Agrees to Provide Cepheid Tuberculosis Test to Global Fund at Cost The tuberculosis test cartridges will be offered at $7.97 each to the Global Fund and less-developed countries eligible for Cepheid's Global Access Program. Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring The test quantifies mutant NPM1 mRNA transcripts in peripheral blood specimens from patients with acute myeloid leukemia. People in the News at Invitae, Cepheid, Nucleai, Angle, Quantum-Si, Twist Bioscience Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of May 22, 2023. Danaher Business Shifts as COVID-19 Revenues Continue to Decline Premium The firm saw total revenues decrease 7 percent, with core revenues down 4 percent and base business core revenue growth of 6 percent. Cepheid Preparing New Infectious Disease Test Launches in 2023, Beyond Premium The firm's planned launches include a respiratory virus panel, a gastrointestinal panel, and a fingerstick tuberculosis test, it revelaed this week at ECCMID. Mar 10, 2023 BioMérieux, Biocartis, Beckman Coulter Gain FDA 510(k) Clearances in February Feb 13, 2023 Boston University, Cepheid Get FDA EUAs for COVID-19, Monkeypox Tests Jan 24, 2023 Danaher Q4 Revenues Rise 3 Percent Despite Difficulties in China Nov 18, 2022 New Products Posted to GenomeWeb: Foundation Medicine, Cepheid, Thermo Fisher, Olink, More Nov 7, 2022 Cepheid Nabs CE Mark for Group B Strep Test Oct 20, 2022 Danaher Q3 Revenues Rise 6 Percent as Businesses Step Back From COVID-19 Products Jul 25, 2022 Highly Anticipated Cepheid Omni Point-of-Care System Falls Off Radar Premium Jul 21, 2022 Danaher Cites Diversified Business, Core Growth, Sustained China Sales as Drivers of Strong Q2 Premium Jun 27, 2022 Cepheid, BioGX to Jointly Develop Monkeypox PCR Test for GeneXpert System May 19, 2022 Cepheid Gets CE Mark for Updated Rapid COVID MDx Test May 12, 2022 Cepheid Adds New Gene Target to SARS-CoV-2 Molecular Test to Account for Variants May 2, 2022 Top Five Articles on GenomeWeb Last Week: Illumina, Janssen Biotech, Cepheid, More Apr 25, 2022 Cepheid Developing Xpert Test to Distinguish Between Bacterial, Viral Infections Premium Jan 27, 2022 Danaher Q4 Revenues Rise 21 Percent Jan 14, 2022 In Brief This Week: BGI, Gencove, Cepheid, Biocartis, Biognosys, Co-Diagnostics, More Oct 21, 2021 Cepheid Sees High Demand for Respiratory Tests Through Remainder of 2021 Premium Oct 14, 2021 Cepheid Obtains CE Mark for Expanded Combo COVID Test Sep 14, 2021 Updated Cepheid SARS-CoV-2, Flu, RSV Test Nabs FDA EUA Jul 30, 2021 Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests Jul 29, 2021 Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests Load More Breaking News Genetic Contributors to Plasma Protein Levels Unearthed in Multiple Studies Standard BioTools, SomaLogic to Merge Arima Genomics, Protean BioDiagnostics Launch 3D Genomics Cancer Testing Joint Venture Pathnostics UTI Test Nabs New York State Approval NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.